Advanced biomarker tests Amprion offers advanced biomarker tests like SYNTap Biomarker Test for accurate detection of alpha-synuclein aggregates, presenting an opportunity for collaborations with research institutions and healthcare providers.
Expansion into CSF biomarker panels The recent launch of cerebrospinal fluid (CSF) biomarker panels by Amprion under SAAmplify opens doors for partnerships with clinics, hospitals, and pharmaceutical companies for early disease diagnosis and monitoring.
Collaboration with NIH researchers Amprion's collaboration with NIH researchers on a Dementia hallmark study not only showcases credibility but also provides a platform to engage with potential customers in the healthcare and research sectors.
SAAmplify as a diagnostic tool The introduction of SAAmplify as a diagnostic tool by Amprion offers an opportunity to target neurologists, scientists, and medical centers seeking innovative solutions for disease diagnosis and monitoring.
Revenue and funding growth potential With a revenue range of $0 - 10M and funding of $11M, Amprion has the potential for growth and expansion, making it an attractive partner for investors looking to capitalize on the biotechnology research market.
Amprion uses 8 technology products and services including Microsoft Clarity, Font Awesome, jQuery Migrate, and more. Explore Amprion's tech stack below.
| Amprion Email Formats | Percentage |
| First.Last@amprionme.com | 42% |
| First@amprionme.com | 35% |
| Last@amprionme.com | 19% |
| First.Middle@amprionme.com | 4% |
| FLast@ampriondx.com | 50% |
| First@ampriondx.com | 50% |
Biotechnology ResearchCalifornia, United States11-50 Employees
Amprion pioneers Testing for diseases associated with mis-folded proteins. Our flagship product - SYNTap is the assay used by the Michael J Fox Foundations Parkinson's Progression and Markers Initiative (PPMI) to define PD and DLB and its stages. Early diagnosis of synucleinopathies can help guide management, treatment and prognostic discussions. https://www.ampriondx.com
Company Overview
Funding & FinancialsAmprion has raised a total of $11M of funding over 1 rounds. Their latest funding round was raised on Jul 15, 2022.
Amprion's revenue is in the range of $10M
Funding & FinancialsAmprion has raised a total of $11M of funding over 1 rounds. Their latest funding round was raised on Jul 15, 2022.
Amprion's revenue is in the range of $10M
Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.
1-888-653-2347 
support@leadiq.com